Q4-FY26 · Manish Gupta
We have done the walk the talk. We have given you a guidance that we'll be looking at beating the market growth and that is what our objective has been.
Jagsonpal Pharmaceuticals · tone and specificity signals across the available quarters.
Language signals
We have done the walk the talk. We have given you a guidance that we'll be looking at beating the market growth and that is what our objective has been.
We are certainly targeting 1.5x of the pharma industry growth. Currently the pharma industry is trending anywhere between 6-7% to 8-9%.
We are not adding any new MR. But we are trying to see whether organically from the same geography we are able to extract more and thereby conserving our cost as well.